AR012377A1 - Esteroides halogenados en 4, su procedimiento de preparacion y compuestos intermedios para esta preparacion, medicamentos y las composiciones farmaceuticas que los contienen. - Google Patents
Esteroides halogenados en 4, su procedimiento de preparacion y compuestos intermedios para esta preparacion, medicamentos y las composiciones farmaceuticas que los contienen.Info
- Publication number
- AR012377A1 AR012377A1 ARP980101631A ARP980101631A AR012377A1 AR 012377 A1 AR012377 A1 AR 012377A1 AR P980101631 A ARP980101631 A AR P980101631A AR P980101631 A ARP980101631 A AR P980101631A AR 012377 A1 AR012377 A1 AR 012377A1
- Authority
- AR
- Argentina
- Prior art keywords
- preparation
- alk
- contain
- pharmaceutical compositions
- intermediate compounds
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
- C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
- C07J41/0077—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 substituted in position 11-beta by a carbon atom, further substituted by a group comprising at least one further carbon atom
- C07J41/0083—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 substituted in position 11-beta by a carbon atom, further substituted by a group comprising at least one further carbon atom substituted in position 11-beta by an optionally substituted phenyl group not further condensed with other rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/30—Oestrogens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Physical Education & Sports Medicine (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Rheumatology (AREA)
- Diabetes (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Endocrinology (AREA)
- Dermatology (AREA)
- Steroid Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Esteroides halogenados en 4 de formula (I): en la que X es un átomo de halogeno, D representa el resto de un ciclo pentagonal o hexagonaleventualmente sustituido y eventualmente portador de una insaturacion, R1 representa un átomo dehidr ogeno, un radical (CH2)m-Ar, (CO)-Ar, CO)-Ar,(CH2)m-Alk o (CO)-Alk, R2 representa un radical que se deriva de un hidrocarburo, lineal o ramificado, saturado o insaturado que contiene de 1 a 6átomos de carbono, R3 y R4 representan unátomo de hidrogeno, un grupo (CH2)m-Het o (CH2)-m-Alk, forman en comun con el átomo de nitrogeno al queestán unidos un heterociclo monociclo o policiclo, saturado o insaturado, aromático o no aromático, de 3 a 15 eslabones queeventualmente contiene de 1a 3 heteroátomos adicionales escogidos entre oxígeno, azufre y nitrogeno, sin sustituir o sustituido, y se escoge entre O, S, SO, SO2 y NH, y n es un numeroentero que varía entre 2 y 8, su procedimiento de preparacion ycompuestos intermedios para esta preparacion, su aplicacion como medicamento y lascomposiciones farmacéuticas que los contienen. Poseen actividades estrogenas, antiestrogenas y antiproliferativas.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR9704321A FR2761992B1 (fr) | 1997-04-09 | 1997-04-09 | Nouveaux steroides 4-halogenes, leur procede et intermediaires de preparation, leur application comme medicaments et les compositions pharmaceutiques les renfermant |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR012377A1 true AR012377A1 (es) | 2000-10-18 |
Family
ID=9505672
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP980101631A AR012377A1 (es) | 1997-04-09 | 1998-04-08 | Esteroides halogenados en 4, su procedimiento de preparacion y compuestos intermedios para esta preparacion, medicamentos y las composiciones farmaceuticas que los contienen. |
Country Status (31)
| Country | Link |
|---|---|
| US (5) | US6239121B1 (es) |
| EP (1) | EP0973793B1 (es) |
| JP (1) | JP4347420B2 (es) |
| KR (1) | KR20010006149A (es) |
| CN (1) | CN1259956A (es) |
| AP (1) | AP1137A (es) |
| AR (1) | AR012377A1 (es) |
| AT (1) | ATE220408T1 (es) |
| AU (1) | AU750030B2 (es) |
| BR (1) | BR9809578A (es) |
| CA (1) | CA2285679A1 (es) |
| DE (1) | DE69806473T2 (es) |
| DK (1) | DK0973793T3 (es) |
| EA (1) | EA002116B1 (es) |
| ES (1) | ES2178208T3 (es) |
| FR (1) | FR2761992B1 (es) |
| HR (1) | HRP980196B1 (es) |
| HU (1) | HUP0002457A3 (es) |
| ID (1) | ID22930A (es) |
| IL (1) | IL132202A (es) |
| NO (1) | NO315049B1 (es) |
| NZ (1) | NZ337947A (es) |
| PL (1) | PL190629B1 (es) |
| PT (1) | PT973793E (es) |
| SK (1) | SK284480B6 (es) |
| TR (1) | TR199902507T2 (es) |
| TW (1) | TW505621B (es) |
| UA (1) | UA57073C2 (es) |
| WO (1) | WO1998045316A1 (es) |
| YU (1) | YU51199A (es) |
| ZA (1) | ZA983046B (es) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2757519B1 (fr) * | 1996-12-23 | 1999-06-11 | Hoechst Marion Roussel Inc | Steroides substitues en position 11, leur procede de preparation, leur application comme medicament et les compositions pharmaceutiques les renfermant |
| FR2780060B1 (fr) | 1998-06-23 | 2000-08-04 | Hoechst Marion Roussel Inc | Nouveaux 19-nor steroides 17-halogenes, procede et intermediaires de preparation, application comme medicaments et compositions pharmaceutiques les renfermant |
| FR2826004B1 (fr) | 2001-06-13 | 2008-03-28 | Aventis Pharma Sa | Procede de preparation de derives estrogenes |
| FR2854402B1 (fr) * | 2003-04-29 | 2008-07-04 | Aventis Pharma Sa | Nouveau procede et intermediaires de preparation de composes 19-nor-steroides |
| KR101129861B1 (ko) * | 2006-12-29 | 2012-04-24 | 에프. 호프만-라 로슈 아게 | 아자스피로 유도체 |
| US20120046461A1 (en) * | 2009-01-23 | 2012-02-23 | Northeastern University | Steroidal anti-hormone hybrids |
| FR2942409B1 (fr) * | 2009-02-20 | 2013-07-26 | Natacha Voillot | Composition pharmaceutique pour la prevention des avortements a repetition. |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2640977A2 (en) * | 1982-06-11 | 1990-06-29 | Roussel Uclaf | New position-11 substituted 19-norsteroids and their application as medicinal products. |
| US4676932A (en) * | 1984-04-09 | 1987-06-30 | The University Of New Mexico | Synthesis of 1-haloestradiols |
| US4859585A (en) * | 1986-04-17 | 1989-08-22 | Trustees Of Tufts College | In-vitro methods for identifying compositions which are agonists and antagonists of estrogens |
-
1997
- 1997-04-09 FR FR9704321A patent/FR2761992B1/fr not_active Expired - Fee Related
-
1998
- 1998-04-01 TW TW087104892A patent/TW505621B/zh not_active IP Right Cessation
- 1998-04-08 PT PT98920587T patent/PT973793E/pt unknown
- 1998-04-08 AT AT98920587T patent/ATE220408T1/de not_active IP Right Cessation
- 1998-04-08 DE DE69806473T patent/DE69806473T2/de not_active Expired - Lifetime
- 1998-04-08 WO PCT/FR1998/000709 patent/WO1998045316A1/fr not_active Application Discontinuation
- 1998-04-08 ID IDW991174A patent/ID22930A/id unknown
- 1998-04-08 AR ARP980101631A patent/AR012377A1/es active IP Right Grant
- 1998-04-08 EA EA199900909A patent/EA002116B1/ru not_active IP Right Cessation
- 1998-04-08 BR BR9809578-1A patent/BR9809578A/pt not_active IP Right Cessation
- 1998-04-08 PL PL98336116A patent/PL190629B1/pl unknown
- 1998-04-08 YU YU51199A patent/YU51199A/sh unknown
- 1998-04-08 JP JP54246298A patent/JP4347420B2/ja not_active Expired - Fee Related
- 1998-04-08 AU AU73396/98A patent/AU750030B2/en not_active Ceased
- 1998-04-08 US US09/402,705 patent/US6239121B1/en not_active Expired - Lifetime
- 1998-04-08 NZ NZ337947A patent/NZ337947A/en unknown
- 1998-04-08 HR HR980196A patent/HRP980196B1/xx not_active IP Right Cessation
- 1998-04-08 CN CN98805963A patent/CN1259956A/zh active Pending
- 1998-04-08 SK SK1362-99A patent/SK284480B6/sk unknown
- 1998-04-08 TR TR1999/02507T patent/TR199902507T2/xx unknown
- 1998-04-08 ES ES98920587T patent/ES2178208T3/es not_active Expired - Lifetime
- 1998-04-08 IL IL13220298A patent/IL132202A/en active IP Right Grant
- 1998-04-08 KR KR1019997009228A patent/KR20010006149A/ko not_active Application Discontinuation
- 1998-04-08 DK DK98920587T patent/DK0973793T3/da active
- 1998-04-08 HU HU0002457A patent/HUP0002457A3/hu unknown
- 1998-04-08 AP APAP/P/1999/001656A patent/AP1137A/en active
- 1998-04-08 CA CA002285679A patent/CA2285679A1/fr not_active Abandoned
- 1998-04-08 EP EP98920587A patent/EP0973793B1/fr not_active Expired - Lifetime
- 1998-04-09 ZA ZA983046A patent/ZA983046B/xx unknown
- 1998-08-04 UA UA99116107A patent/UA57073C2/uk unknown
-
1999
- 1999-10-08 NO NO19994908A patent/NO315049B1/no not_active IP Right Cessation
-
2000
- 2000-12-08 US US09/733,377 patent/US6472382B2/en not_active Expired - Lifetime
- 2000-12-22 US US09/746,245 patent/US6462211B1/en not_active Expired - Lifetime
-
2001
- 2001-01-10 US US09/757,678 patent/US20010005756A1/en not_active Abandoned
- 2001-01-10 US US09/757,679 patent/US6399766B2/en not_active Expired - Lifetime
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GT199900008A (es) | Compuestos 4-(2-ceto-1-benzilimidazolinil) piperidina como agonistas del receptor orl1 | |
| MX9300786A (es) | Compuestos hipolipidaemicos. | |
| ES2071989T3 (es) | Analogos de oligonucleotidos. | |
| ES2028857T3 (es) | Procedimiento para la preparacion de derivados de amino-tiazol y amino-oxazol. | |
| AR031680A1 (es) | Utilizacion de acrilamidas de quinuclidina para la preparacion de medicamentos, compuestos y composicion farmaceutica | |
| UY27457A1 (es) | Derivados de 1,8-naftiridina y su uso para el tratamiento de la diabetes y trastornos relacionados | |
| PA8582901A1 (es) | Compuestos de piperidinil-imidazopiridina n- sustituidos como moduladores del receptor 5 ht4 | |
| ES2054860T3 (es) | Nuevos derivados de 9-halogeno-(z)-prostaglandinas, procedimiento para su preparacion, asi como a su utilizacion como medicamentos. | |
| MX9300977A (es) | Compuetos heterobiciclicos. | |
| AR042437A1 (es) | Derivados de fluoroglicosidos heterociclicos, medicamentos que los contienen y usos | |
| ES2067448T3 (es) | Amidas de acidos piridina-2,4- y -2,5-dicarboxilicos, procedimiento para su preparacion, utilizacion de las mismas, asi como medicamentos a base de estos compuestos. | |
| ES2054716T3 (es) | Bis-naftalimidas, su obtencion y empleo. | |
| ES2169147T3 (es) | Derivados de beta-carbolina agonistas de la melatonina, sus procedimientos de preparacion y su utilizacion a titulo de medicamento. | |
| AR012377A1 (es) | Esteroides halogenados en 4, su procedimiento de preparacion y compuestos intermedios para esta preparacion, medicamentos y las composiciones farmaceuticas que los contienen. | |
| ES2026669T3 (es) | Procedimiento para la preparacion y el uso terapeutico de los beta-d-fenil tioxilosidos. | |
| ES2115220T3 (es) | Nuevo uso de compuestos bis-heterociclicos como agentes antiinflamatorios y composiciones farmaceuticas de los mismos. | |
| ES2070002T3 (es) | Composiciones terapeuticas a base de derivados de 1,2-ditiol-3-tiona. | |
| MX9401080A (es) | Compuestos heteroaromaticos. | |
| MX9303903A (es) | Derivados de 2-imidazolina-5-onas y 2-imidazolina-5-tionas, procedimiento para su preparacion y composiciones fungicidas que los contienen. | |
| ES2054811T3 (es) | Derivados de tetrahidroisoquinolin-2-ilo como antagonistas de tromboxano a2. | |
| NO20012817D0 (no) | Phenethyl-5-bromopyridylthiourea (PBT) og dihydroalkoxybenzyloxopyrimidine (DABO) derivater som utöverspermicidal aktivitet | |
| AR006706A1 (es) | Productos esteroides, su aplicacion en calidad de medicamento, su procedimiento de preparacion, los compuestos intermedios para este procedimiento, y las composiciones que los contienen | |
| ES2073393T3 (es) | Derivados de acidos 2,4- y 2,5-dicarboxilicos, procedimiento para su preparacion, utilizacion de los mismos asi como medicamentos a base de estos compuestos. | |
| ES2164400T3 (es) | Esteroides con actividad anticonceptiva y antiosteoporotica. | |
| ES2029879T3 (es) | Procedimiento para producir derivados de aminas sustituidas. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant, registration |